LEADER 05022nam 2201189z- 450 001 9910557113103321 005 20210501 035 $a(CKB)5400000000040915 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69294 035 $a(oapen)doab69294 035 $a(EXLCZ)995400000000040915 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPharmaceutical Residues in the Environment 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (292 p.) 311 08$a3-03943-485-3 311 08$a3-03943-486-1 330 $aPharmaceuticals, due to their pseudo-persistence and biological activity as well as their extensive use in human and veterinary medicine, are a class of environmental contaminants that is of emerging concern. In contrast to some conventional pollutants, they are continuously delivered at low levels, which might give rise to toxicity even without high persistence rates. These chemicals are designed to have a specific physiological mode of action and to resist frequently inactivation before exerting their intended therapeutic effect. These features, among others, result in the bioaccumulation of pharmaceuticals which are responsible for toxic effects in aquatic and terrestrial ecosystems. It is extremely important to know how to remove them from the environment and/or how to implement procedures or treatments resulting in their biological inactivation. Although great advances have been made in their detection in aquatic matrices, there remains limited analytical methodologies available for the trace analysis of target and non-target pharmaceuticals in matrices such as soils, sediments, or biota. There are still many gaps in the data on their fate and behavior in the environment as well as on their threats to ecological and human health. This book has included nine current research and three review articles in this field. 606 $aEnvironmental economics$2bicssc 606 $aResearch and information: general$2bicssc 610 $a5-fluorouracil 610 $aactivated sludge (AS) 610 $aantibiotic resistance 610 $aantibiotic resistance genes 610 $aantibiotic resistance genes (ARGs) 610 $aantibiotic-resistant bacteria (ARB) 610 $aantibiotics 610 $aantibiotics, antibiotic resistance 610 $aaquatic compartments 610 $abacterial community 610 $aBDD anode 610 $achromatographic methods 610 $aconstructed wetlands 610 $aconstructed wetlands (CWs) 610 $aconventional wastewater treatments 610 $acyclophosphamide 610 $acytostatic drug 610 $adetermination of pharmaceuticals 610 $adetermining target pollutants in plant materials 610 $adevelopment of methods 610 $aecotoxicity 610 $aelectrochemical oxidation 610 $aelectromigration techniques 610 $aendocrine disrupting compounds 610 $aenvironmental and biological samples 610 $aenvironmental contaminants 610 $aenvironmental pollution 610 $aenvironmental risk assessment 610 $afate in the environment 610 $afate in WWTPs 610 $afluoxetine 610 $agreen chemistry 610 $ahydroponic cultivation 610 $aifosfamide 610 $aintermediates 610 $aionic liquids 610 $aLC-MS/MS analysis 610 $alincomycin 610 $amianserin 610 $amigration 610 $amonensin 610 $amunicipal wastewater treatment plants 610 $aparoxetine 610 $apharmaceutical residues 610 $apharmaceuticals 610 $apharmaceuticals in the environment 610 $apharmaceuticals occurrence 610 $apharmaceuticals toxicity 610 $apoultry farms 610 $aremoval efficiency 610 $aresidual 610 $arisk assessment 610 $aroxarsone 610 $asample preparation 610 $asertraline 610 $asewage sludge 610 $asoil 610 $asolid phase extraction 610 $aSpirotox 610 $aspread of resistance 610 $asul genes 610 $asulfamethoxazole 610 $asulfonamides 610 $atetracyclines 610 $atoxicity 610 $aultra-high performance liquid chromatography 610 $awastewater 610 $awastewater treatment plants (WWTPs) 610 $awastewaters 615 7$aEnvironmental economics 615 7$aResearch and information: general 700 $aKumirska$b Jolanta$4edt$01290947 702 $aKumirska$b Jolanta$4oth 906 $aBOOK 912 $a9910557113103321 996 $aPharmaceutical Residues in the Environment$93021677 997 $aUNINA